三只产品同日首发，第二批新型浮动费率基金来了

Group 1 - Three new floating rate funds were launched on August 4, including E Fund Value Return Mixed, China Europe Core Smart Mixed, and CCB Medical Innovation Stock, with fundraising periods ending on August 20, August 15, and August 22 respectively [2][3] - The issuance scale for CCB Medical Innovation Stock is capped at 3 billion yuan [3] - The new floating rate funds feature differentiated performance benchmarks, which will influence the fee rates based on the funds' performance relative to these benchmarks [1][4] Group 2 - The performance benchmark for China Europe Core Smart Mixed is set as: 80% of the CSI 800 Index return + 5% of the CSI Hong Kong Stock Connect Composite Index (RMB) return + 15% of the China Bond Composite Index return [4] - E Fund Value Return Mixed has a performance benchmark of: 55% of the CSI 800 Index return + 20% of the CSI Hong Kong Stock Connect Composite Index return + 25% of the China Bond Total Index return [4] - CCB Medical Innovation Stock's performance benchmark is: 70% of the CSI Medical and Health Index return + 15% of the China Bond Composite Index return + 15% of the Hang Seng Healthcare Index return [4] Group 3 - The funds are designed to invest in both A-shares and Hong Kong stocks, with a maximum of 50% of stock assets allocated to Hong Kong Stock Connect stocks [3] - The management fee structure includes three tiers: 1.2% for the benchmark tier, 1.5% for the upgrade tier, and 0.6% for the downgrade tier, based on the fund's performance after one year [5] - The funds aim to enhance the holding experience through a quarterly dividend mechanism, with China Europe Core Smart Mixed implementing a "performance-based quarterly dividend" clause [1][3]